Cubist Systematic Strategies’s Ligand Pharmaceuticals LGND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-23,149
Closed -$1.7M 2680
2023
Q1
$1.7M Sell
23,149
-28,005
-55% -$2.06M 0.01% 1204
2022
Q4
$3.42M Buy
51,154
+35,249
+222% +$2.35M 0.02% 938
2022
Q3
$854K Sell
15,905
-12,592
-44% -$676K ﹤0.01% 2170
2022
Q2
$1.59M Buy
28,497
+8,544
+43% +$476K 0.01% 1758
2022
Q1
$1.4M Buy
19,953
+14,958
+299% +$1.05M 0.01% 1770
2021
Q4
$481K Buy
4,995
+1,619
+48% +$156K ﹤0.01% 2478
2021
Q3
$293K Sell
3,376
-5,944
-64% -$516K ﹤0.01% 2375
2021
Q2
$763K Sell
9,320
-21,696
-70% -$1.78M 0.01% 1743
2021
Q1
$2.95M Sell
31,016
-9,168
-23% -$872K 0.04% 766
2020
Q4
$2.49M Buy
40,184
+27,923
+228% +$1.73M 0.03% 809
2020
Q3
$729K Sell
12,261
-8,743
-42% -$520K 0.01% 1513
2020
Q2
$1.47M Sell
21,004
-20,081
-49% -$1.4M 0.03% 974
2020
Q1
$1.86M Buy
41,085
+37,631
+1,089% +$1.71M 0.05% 498
2019
Q4
$225K Sell
3,454
-73,086
-95% -$4.76M ﹤0.01% 1989
2019
Q3
$4.75M Buy
76,540
+31,980
+72% +$1.99M 0.09% 313
2019
Q2
$3.17M Buy
44,560
+11,224
+34% +$799K 0.06% 463
2019
Q1
$2.61M Buy
33,336
+21,148
+174% +$1.66M 0.08% 335
2018
Q4
$1.03M Buy
+12,188
New +$1.03M 0.05% 551
2017
Q1
Sell
-5,976
Closed -$379K 1738
2016
Q4
$379K Buy
+5,976
New +$379K 0.03% 831
2016
Q3
Sell
-4,593
Closed -$342K 1778
2016
Q2
$342K Buy
+4,593
New +$342K 0.02% 1001
2016
Q1
Sell
-5,368
Closed -$363K 1735
2015
Q4
$363K Buy
+5,368
New +$363K 0.02% 1002
2015
Q2
Sell
-7,539
Closed -$363K 1938
2015
Q1
$363K Buy
7,539
+5
+0.1% +$241 0.02% 1141
2014
Q4
$250K Sell
7,534
-763
-9% -$25.3K 0.01% 1352
2014
Q3
$243K Buy
+8,297
New +$243K 0.01% 1241